Poised for Rapid Expansion, World Blood Market Exceeds $20 Billion

New York, October 22, 2006 — Human-derived blood products, testing and typing products, and plasma and blood collection equipment continue to be hot global commodities as the market surpassed $20 billion is revenues at the end of 2005.

According to the latest market research from Kalorama Information, The Worldwide Market for Blood Products, Blood Testing, Blood Equipment and Synthetic Blood products, the total global value of blood products alone is just shy of $14 billion in 2005, with the lions share attributable to red blood cells (RBCs) at more than $7 billion.

Demand for immunoglobulins or antibodies stood at nearly $3 billion in 2005 and is rising by 6%-8% per year, making it the driving force behind plasma collection. Other human plasma-derived products, such as platelets, clotting factors, and alph-1 proteinase inhibitors, also played a significant role in strong revenues, valued at $2.5 billion.

At the same time the blood products market escalates, so too are the markets for blood testing and typing products, blood collection equipment, and synthetic blood products. Nucleic acid tests, for example, currently at $953 million, will increase by 11.5% to over $2 billion by 2012. Similarly, the market for recombinant factors, which currently stands at over $4 billion, is expected to rise to more than $7 billion by 2012.

“Global demand for blood products, particularly in developed countries where the technology is readily available and rapidly advancing, will continue to rise at a healthy rate as the world population ages and requires increasingly intricate operations and testing,” notes Alison Sahoo, the report’s author. “As they reach the market by 2007, we also anticipate the emergence of hemoglobin-based oxygen carriers (HBOCs) and PFC-based products to play a significant role in market growth.”

The in-depth analysis contained in The Worldwide Market for Blood Products is the most comprehensive evaluation of the blood industry market available. The report covers research and development pipelines, in-depth company profiles, regulatory, business, and clinical challenges facing the various sectors, and market forecasts through 2012. It can be purchased directly from Kalorama Information by clicking http://www.kaloramainformation.com/pub/1271165.html. It is also available at MarketResearch.com.

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent market research for the life sciences. For more information, contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com, or visit www.KaloramaInformation.com.